The economics of the NHS cancer drugs fund
Appl Health Econ Health Policy
.
2011 May 1;9(3):137-8.
doi: 10.2165/11585750-000000000-00000.
Authors
Alan Maynard
1
,
Karen Bloor
Affiliation
1
Department of Health Sciences, University of York, York, UK. alan.maynard@york.ac.uk
PMID:
21506619
DOI:
10.2165/11585750-000000000-00000
No abstract available
MeSH terms
Antineoplastic Agents / economics*
State Medicine*
United Kingdom
Substances
Antineoplastic Agents